NBP
NovaBridge Biosciences
1.40$
-1.4%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +131.7% | -26.9% | +264.5% | -86.1% | +363.6% | -90.9% | +320.8% | -97.6% | |
| – | +194.5% | -33.2% | +292.5% | -86.0% | +383.4% | -90.9% | +290.9% | -97.6% | |
| – | +415.8% | -28.4% | +318.4% | -88.4% | +481.4% | -90.9% | +70.9% | -94.0% | |
| – | +221.2% | -36.6% | +309.6% | -86.0% | +414.1% | -91.0% | +306.0% | -97.6% | |
| – | +125.7% | +490.2% | +547.5% | -83.0% | -92.1% | -61.9% | +366.7% | -97.0% | |
| – | – | – | – | – | -1,978.7% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | -84.3% | +537.4% | -100.0% | – | – | |
| – | +0.0% | +0.0% | -19.1% | -84.4% | +533.3% | -86.0% | – | – | |
| – | +151.4% | +13.2% | -81.1% | -77.1% | +551.9% | -88.1% | -33.4% | -95.0% | |
| – | +77.4% | +70.0% | -2.1% | -83.0% | +573.9% | -91.2% | +6.1% | -93.8% | |
| – | -19.2% | -29.0% | -85.8% | -40.3% | +29.3% | -89.9% | +851.4% | -97.9% | |
| – | – | – | – | – | – | – | – | – | |
| – | -332.7% | – | +426.2% | -87.3% | +320.6% | -91.9% | +505.2% | -97.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +17.5% | +11.1% | +8.6% | +0.9% | -2.5% | -48.7% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.